Veterinary vaccines are used for prevention of diseases that affect animals. Animal vaccination is a cost-effective solution to maintain animal health and sustainability, offering various benefits such as improved animal health & welfare of companion animals, improvement in livestock products, and prevention of transmission of diseases from animal to humans. Humans are largely dependent on animals, as they are the major source of milk, meat, and other dairy products. Thus, with increase in population, the demand for animal products also increases, fueling the production of vaccines for cattle, pigs, poultry, and sheep.
The growth of animal vaccines market is driven by increase in healthcare spending by governments. In addition, rise in consumption of meat, milk, and protein; and extensively growing pet ownership drive the market. However, lack of awareness toward pet health and expensive storage & production of vaccines are expected to restrain the growth of the market.
KEY BENEFITS
The global animal vaccines market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
The market scenario is comprehensively analyzed with respect to the product type and animal type.
Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
In-depth geographical analysis helps to understand the regional market, which assists in strategic business planning.
KEY MARKET SEGMENTS
By Product
Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines
By Animal Type
Companion Animals
Dogs
Cats
Others
Cattle
Pigs
Poultry
Sheep
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Rest of LAMEA
The key players profiled in this report include the following:
Bayer AG
Eli Lilly and Company
Boehringer
Ingelheim GmbH
Merck & Co., Inc.
Zoetis Inc.
Ceva Sante Animale
Sanofi S.A.
Nutreco N.V.
Virbac S.A.
The other players of the animal therapeutics and diagnostics market include (companies not profiled in the report):
Nexvet
PHL Associates, Inc.
Hygieia Biological Laboratories
Colorado Serum Company
Pfizer
Arko Laboratories, Ltd.
